loading...
Del.icio.us
Google
Yahoo MyWeb
Facebook
BioImagene Overview
BioImagene is pioneering innovative solutions in the life sciences and digital pathology markets targeted to the specific needs of pathologists, researchers and drug developers.
They believe that applying image informatics solutions can significantly boost productivity, ensure accuracy and efficiency and reduce bottlenecks in all aspects of life science workflows.
Their clear competitive...More»
BioImagene is pioneering innovative solutions in the life sciences and digital pathology markets targeted to the specific needs of pathologists, researchers and drug developers.
They believe that applying image informatics solutions can significantly boost productivity, ensure accuracy and efficiency and reduce bottlenecks in all aspects of life science workflows.
Their clear competitive advantage comes from the combination of our deep domain knowledge, enterprise standard technology solutions and our global presence. They foster a customer centric corporate culture with a focus on innovation. They are an established solutions provider with dependable partners and marquee customers. They have successfully provided solutions to twelve of the world’s leading pharmaceutical companies, premier anatomic pathology research laboratories and institutions worldwide.«Less
Key People
Management
- Mohan Uttarwar, President and CEO
- Vivek Pathak, Chief Financial Officer and Treasurer
- Bikash Sabata, Chief Technology Officer
- Mike Cusack, Vice President Marketing
- Suzanne Mattingly, VP Sales & Marketing
- Mark Meyers, VP Sales
- Abhi Gholap, VP Operations
- Gregory Loney, VP Instrumentation
- Gauri Naik, Principal Scientist
- Steve Barbee, VP Sales
- Prashant Kulkarni, VP Engineering
- Neil Dey, VP Business Development
- Sanford Barsky, Medical Director
- Robert Van Sluis, VP Sales
- Raggy Bains, Director of Sales
- Lokesh Tatke, Director of Technology
- Himanshu Ubale, VP Engineering
- Aparna Joshi, Associate Medical Director
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| Unknown | Series A | 1.2M | Unknown |
|
| 01/2002 | Seed | 0.125M | Unknown |
|
| 10/2004 | Series B | 4.2M | 12M | |
| 10/04/2004 | Series C | 4.2M | Unknown | |
| 08/20/2008 | Series D | 26M | Unknown |
Products
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
No related companies were found.
Page Information
09/10/2008 02:42AM by TradeVibes
User Opinions
Bulls vs. Bears (1)
| Bullish Opinions (1) | Author/Date | Do you agree? | |
|---|---|---|---|
|
Digital pathology/ imaging helps clinicians and researchers |
sherr 08/20/2008 |
  |
100% 1 vote 1 0% 0 |
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »
Web Metrics
View All Web Metrics »
| Alexa Rank: | 504620 |  |
925700 |
| Yahoo Search Results: | 37,000 | ||
News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
BioImagene Adds Siemens As Investor
Oct 16, 2008 - 0 comments
BioImagene Gets $26M In Series D Funding
Aug 20, 2008 - 0 comments
Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.